Orlando, Fla.—A small retrospective study suggests that immunotherapy may be less effective in patients who have received antibiotics within a month of starting their therapy. The findings were reported at the 2017 Genitourinary Cancers Symposium.
Investigators retrospectively analyzed data from 80 patients with metastatic renal cell carcinoma who were treated with programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors alone or in combination, in prospective trials at the